Evidence of a new potential therapeutic target — a protein called free fatty acid receptor 4 (FFA4) — in…
Forest Ray PhD
Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Forest Ray PhD
Verona Pharma has started the second part of a Phase 2 trial evaluating its investigational therapy ensifentrine (RPL544)…
Patients with chronic obstructive pulmonary disease (COPD) should be more cautious when taking metformin, a common medication used…
Younger patients report feeling a heavier burden and greater daily impact from the symptoms of chronic obstructive pulmonary disease…
Chronic obstructive pulmonary disease (COPD) appears to be a risk factor for lung cancer, liver cancer, and colorectal cancer,…
Having small airways compared to lung size may contribute to the development of chronic obstructive pulmonary disease (COPD) in many…
As air pollution levels fall in the wake of widespread lockdowns due to the COVID-19 pandemic, one in six…